Free Trial Information
BioCentury | Mar 7, 2011
Company News

3M, U.K. Ministry of Defence diagnostic news

...details were not disclosed (see BioCentury, Feb. 19, 2007). 3M Co. (NYSE:MMM), St. Paul, Minn. U.K. Ministry of Defence...
Read More
BioCentury | Oct 11, 2010
Company News

DynPort, U.K. Ministry of Defence infectious news

...was no Animal Rule equivalent in the EU. DynPort Vaccine Co. LLC , Frederick, Md. U.K. Ministry of Defence...
Read More
BioCentury | Feb 22, 2010
Company News

Isogenica, U.K. Ministry of Defence deal

...partner the peptides. Further financial terms were not disclosed. Isogenica Ltd. , Little Chesterford, U.K. U.K. Ministry of Defence...
Read More
BioCentury | Feb 23, 2009
Company News

Defyrus, U.K. Ministry of Defence deal

...will receive undisclosed upfront payments plus potential milestones and royalties. Defyrus Inc. , Toronto, Ontario U.K. Ministry of Defence...
Read More
BioCentury | Nov 24, 2008
Company News

Novacta Ltd., Ministry of Defence deal

The ministry will evaluate Novacta's lantibiotics for antiviral use. Novacta's Novacta Therapeutics unit is developing NVB302 , a preclinical lantibiotic, to treat Clostridium difficile infection. Financial terms were not disclosed. Novacta Ltd. , Welwyn Garden City, U.K.,...
Read More
BioCentury | May 26, 2008
Company News

Archimedes, U.K. Ministry of Defence deal

...terms were not disclosed (see BioCentury, June 25, 2007). Archimedes Pharma Ltd. , Reading, U.K. U.K. Ministry of Defence...
Read More
BioCentury | Sep 27, 1999
Company News

Biotrace, Graseby Dynamics Ltd. deal

...technical expertise for the detection of biological and chemical agents to aid in designing the U.K. Ministry of Defence's...
Read More
BioCentury | Jan 25, 1999
Company News

Implyx Ltd., U.K. Ministry of Defence other research news

...a research program in anthrax and other toxin- and viral-mediated diseases. Implyx Ltd., Hoddesdon, U.K. U.K. Ministry of Defence...
Read More
Items per page:
1 - 8 of 8
BioCentury | Mar 7, 2011
Company News

3M, U.K. Ministry of Defence diagnostic news

...details were not disclosed (see BioCentury, Feb. 19, 2007). 3M Co. (NYSE:MMM), St. Paul, Minn. U.K. Ministry of Defence...
Read More
BioCentury | Oct 11, 2010
Company News

DynPort, U.K. Ministry of Defence infectious news

...was no Animal Rule equivalent in the EU. DynPort Vaccine Co. LLC , Frederick, Md. U.K. Ministry of Defence...
Read More
BioCentury | Feb 22, 2010
Company News

Isogenica, U.K. Ministry of Defence deal

...partner the peptides. Further financial terms were not disclosed. Isogenica Ltd. , Little Chesterford, U.K. U.K. Ministry of Defence...
Read More
BioCentury | Feb 23, 2009
Company News

Defyrus, U.K. Ministry of Defence deal

...will receive undisclosed upfront payments plus potential milestones and royalties. Defyrus Inc. , Toronto, Ontario U.K. Ministry of Defence...
Read More
BioCentury | Nov 24, 2008
Company News

Novacta Ltd., Ministry of Defence deal

The ministry will evaluate Novacta's lantibiotics for antiviral use. Novacta's Novacta Therapeutics unit is developing NVB302 , a preclinical lantibiotic, to treat Clostridium difficile infection. Financial terms were not disclosed. Novacta Ltd. , Welwyn Garden City, U.K.,...
Read More
BioCentury | May 26, 2008
Company News

Archimedes, U.K. Ministry of Defence deal

...terms were not disclosed (see BioCentury, June 25, 2007). Archimedes Pharma Ltd. , Reading, U.K. U.K. Ministry of Defence...
Read More
BioCentury | Sep 27, 1999
Company News

Biotrace, Graseby Dynamics Ltd. deal

...technical expertise for the detection of biological and chemical agents to aid in designing the U.K. Ministry of Defence's...
Read More
BioCentury | Jan 25, 1999
Company News

Implyx Ltd., U.K. Ministry of Defence other research news

...a research program in anthrax and other toxin- and viral-mediated diseases. Implyx Ltd., Hoddesdon, U.K. U.K. Ministry of Defence...
Read More
Items per page:
1 - 8 of 8